Entelos Inc


US-based Entelos Inc develops predictive biosimulation models, which can be used instead of animals to test drugs. Clinical testing can be done from inception to the point where there is a product. Pfizer is a shareholder and other users of the models include Lilly, Johnson & Johnson and Unilever. It can be used for drugs and consumer products. It is estimated that Entelos' technology could cut the cost of developing a drug by $125m. Entelos joined Aim on 12 April 2006, when it raised £11.4m at 82.75p.

Sector: Health

News blog

Browse by issue
All issues
Popular tags
All tags

betbrokers, financial, gold, health, leisure, media, mobile, resources, services, technology

AIM Micro feeds

Keep up to date with articles published at Subscribe to AIM Micro RSS Feeds